Hemas Holdings Ltd. · CSELK:HHL.N0000
Hemas — Q2 FY24/25 Earnings Presentation
32 slides from Hemas's earnings presentation, 2024
Slide 1: Hemas Holdings PLC Investor Presentation Q2 FY24/25
Hemas Holdings PLC Investor Presentation- Q2 FY24/25
Slide 2: Who we are
Who we are Established in 1948, with a purpose of empowering families to live a better tomorrow, Hemas Holdings is one of Sri Lanka’s leading conglomerates listed in the Colombo Stock Exchange with focused interest in Consumer Brands and Healthcare. USD 1948 2003 2007 2013 2018 2022 75 166mn Years i
Slide 3: Implications of key macro economic parameters on Hemas
Implications of key macro economic parameters on Hemas Interest Rates Stable Exchange Rates Global Commodity prices “ Mixed impact of reduced prices “A gradual decline in AWPLR was “Positive impact from reduced RM of key commodities which witnessed during the year easing costs and import expenditure
Slide 4: Corporate Governance
Corporate Governance BOM Group CEO Nomination & Governance BOM (Board of Management) Consists of the senior leadership team of 11 members - Heads of our 6 businesses and 5 leaders from Corporate Committee Office. BOM is responsible for formulation and implementation of Group strategic plan and ensur
Slide 5: How do we bring purpose to life
How do we bring purpose to life Passion for Obsession Concern for VALUES Driven by Customer for People Innovation Performance Outcome Consumer Driven Centric COMPETENCIES Eliminating Growth-Driven Empower families to aspire for a Purpose Inequality Mindset better tomorrow Our 2030 aspiration Revenue
Slide 6: Group Performance
Group Performance Revenue (LKR Mn) 5 Year CAGR 13.7% 113,940 121,614 78,831 60,043 64,501 2020 2021 2022 2023 2024 EBIT (LKR Mn) and EBIT Margin Earnings (LKR Mn) and Earnings Margin 5 Year CAGR 16.1% 5 Year CAGR 12.6% 9.4% 9.6% 9.8% 5.4% 6,109 5.0% 8.6% 10,963 11,921 4,249 4,269 5.9% 6,783 3,253 5.
Slide 7: Long range plan: Key strategic pillars
Long range plan : Key strategic pillars Refreshing High A Enhancing the growth successful efficiencies portfolio spaces turnaround Consumer Brands Pursuing scalable Morison will pivot to Enhance efficiency aims to expand its opportunities across branded and market position presence in the South Asia
Slide 8: Long range plan: Key focus areas
Long range plan : Key focus areas ❖ Invest in complementary Hair and ❖ Shift focus to growing the ❖ Continue to strengthen a lean Beauty care, focus on local Morison brand in cardiac, diabetes, business model consumer needs, and drive and complementary medication, household penetration in while enha
Slide 9: Awards and Recognitions
Awards and Recognitions National Convention on Quality and Productivity Hemas Hospitals & Laboratory Services Celebrates 13 Gold Awards LMD’s Most Respected Entities in SL 2024 Morison named as the “Sector Winner for Pharmaceuticals” in LMD’s Most Respected Entities in SL 2024 Hemas has been recogni
Slide 10: New Product Launches during the Quarter
New Product Launches during the Quarter Home and Personal Care Pharmaceuticals Manufacturing BisoMor blister BABY HUGS SOAP BABY HUGS SOAP BABY HUGS SOAP packs (Bisoprolol KOHOMBA ALOE 75G MILK ALMOND 75G SANDALWOOD TUMERIC BP 2.5mg & 5mg 75G 30s) SalMor (Salbutamol Oral Solution BP 2mg/5ml 100ml) G
Slide 11: New Product Launches during the Quarter
New Product Launches during the Quarter Learning Segment “The core portfolio maintained robust performance, demonstrating its market strength, while new product launches gained BlockBuddies CraftBuddies CraftBuddies Premium Blocks colour sand Finger Paint positive momentum. This success highlights t
Slide 12: Financial Snapshot
Financial Snapshot EBIT by Segment (LKR million) 3,093 2,766 2,695 247 272 501 1,930 6M contribution to the Group 1,547 1,477 1,664 455 37% 62% 2% 230 1,211 816 668 4% 47% 1,616 1,554 15% Revenue 1,393 1,287 995 (410) (574) (397) (628) EBIT (346) FY22 Q2 FY23 Q2 FY24 Q2 FY25 Q2 FY25 Q1 Consumer Heal
Slide 13: Sector Performance Summary – Q2 FY 2024-25
Sector Performance Summary – Q2 FY 2024-25 Revenue Walk EBIT Walk (LKR Mn) (LKR Mn)
Slide 14: Continuing Operation EPS – Q2 FY 2024-25
Continuing Operation EPS – Q2 FY 2024-25 EPS Walk (LKR Per Share)
Slide 15: Capital Employed – FY 2024-25
Capital Employed – FY 2024-25 Sector Efficiency Capital Employed, ROCE, and EBIT by Sector 60% Mobility Consumer 50% LKR 726.7 Mn LKR 2,479,7 Mn 42.5% 40% 38.9% Healthcare LKR 2,841.5 Mn 30% Group ROCE : 23.5 % ROCE (%) 20% 20.9% 10% 0% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 -10% -10.7% C
Slide 16: Consumer Brands
Consumer Brands ❖ Home and Personal Care - Sri Lanka ❖ Home and Personal Care - International ❖ Learning Segment
Slide 17: Consumer Brands
Consumer Brands Contribution to Group Sector Performance – 6M FY 2024-25 37% Revenue % Revenue (LKR Mn) Key Highlights 6M FY25 6M FY24 38% 15,433 -4.6% • During the quarter, the strengthening 12,741 (YoY) of the domestic currency and declining 11,521 10,991 global commodity prices have led to 8,865
Slide 18: Home and Personal Care – Sri Lanka
Home and Personal Care – Sri Lanka 8 Key categories with market Purpose-driven brands touching the lives of the Sri Lankan consumer leading positions Extensions to the Portfolio Inclusive Strong roots Parenting Stronger Make a Celebrating Enabling Both parents together Positive Difference & Nurturin
Slide 19: Home and Personal Care – International
Home and Personal Care – International Locally led and localised in Bangladesh Reach in Bangladesh 2 Geographies Bangladesh & West Bengal • All products are exclusively designed for Bangladesh. Rural penetration by • Extensive product portfolio with multiple value 19.3% Hemas Key categories 3• Value
Slide 20: Home and Personal Care – Sri Lanka and International
Home and Personal Care – Sri Lanka and International Sri Lanka International Revenue Revenue Revenue (LKR Mn) • Despite the challenging market conditions, • Although overall industry demand declined, -17.1% ‘Kumarika’ increased its market share in the VAHO company witnessed improvements in overall (
Slide 21: Learning Segment
Learning Segment Revenue • Despite severe competition in the market, 7 the company has successfully maintained Key categories its leading position by adapting to Revenue (LKR Mn) evolving consumer preferences for high quality products at competitive pricing. • To mitigate the impact of seasonal High
Slide 22: Healthcare Sector
Healthcare Sector ❖ Pharmaceutical Import, Marketing and Distribution ❖ Pharmaceutical Manufacturing ❖ Hospitals
Slide 23: Healthcare
Healthcare Contribution to Group Sector Performance – 6M FY 2024-25 Revenue % 62% Revenue (LKR Mn) -2.6% Key Highlights (YoY) 6M FY25 6M FY24 60% 17,912 18,237 17,442 16,130 15,326 • During the quarter under review, the pharmaceutical industry experienced volume growth, for the first time EBITDA % s
Slide 24: Pharmaceutical Import, Marketing, Distribution and Manufacturing
Pharmaceutical Import, Marketing, Distribution and Pharmaceutical Manufacturing Revenue • The Distribution business continues to hold its market-leading position this quarter Revenue (LKR Mn) • Aligned with its mission to make premium healthcare accessible, the Pharmaceutical Manufacturing business
Slide 25: Hospitals
Hospitals Revenue • A decline in hospital admissions was reported, Revenue (LKR Mn) primarily due to a reduction in communicable 190+ Beds 17.9 % diseases compared to the same period last year. • In contrast, there has been an uptick in (YoY) outpatient volumes, fueled by increased medical 2,247 scr
Slide 26: Mobility Sector
Mobility Sector ❖Maritime ❖Aviation
Slide 27: Mobility
Mobility Contribution to Group Sector Performance – 6M FY 2024-25 2% Revenue % Revenue (LKR Mn) 26.7% Key Highlights 6M FY25 (YoY) 1% 6M FY24 460 458 476 477 376 • The maritime sector experienced a positive boost in both volume and freight rates. EBITDA % 13% • Amidst aggressive competition in the a
Slide 28: Environmental Agenda 2030
Environmental Agenda 2030 ENCOURAGING RESPONSIBLE PROTECTING SRI LANKAN ENDEMISM PLASTIC CONSUMPTION Reintroducing two critically endangered 830,000+ KG plants to their natural habitat in the Mahakudugala Forest Reserve, Nuwara To Date Plastic Collection Eliya, and Horton Plains National Park.
Slide 29: Social Impact: 56,800+ Families Empowered
Social Impact: 56,800+ Families Empowered TACKLING PERIOD POVERTY ENABLING WOMEN TO BETTER MANAGE CREATING A SAFER WORLD CREATING EQUAL LEARNING WORK-LIFE STRESS OPPURTUNITY 33,950 145 8,966 43,012 Women and Girls Women Children, Teachers and Parents Families CREATING QUALITY LEARNING ENSURING NO CH
Slide 30: Sustainability Performance – Q2 2024-25 vs Q2 2023-24
Sustainability Performance – Q2 2024 – 25 vs Q2 2023 - 24 Values of Fines for Non-Compliance Carbon Footprint (per Rs. Mn Revenue) 1.1% 0.10MT with Laws and Regulations in the NONE Social Economic Area Water Consumption Total Work-Related Injury Rate (per Rs. Mn Revenue) 11.8% 1.5 m3 (per 100 employ
Slide 31: Key Priorities
Key Priorities Focus on Personal care, Beauty and wellness with a drive for premiumisation and exploring underpenetrated Markets Corporate Priorities Strengthening value prepositions to grow market share Accelerating the M&A opportunities Accelerate exports and international expansion Consumer Drivi
Slide 32: Disclaimer
Disclaimer The material in this presentation has been prepared by Hemas Holdings PLC (“Hemas”) and is general background information about Hemas’ activities current as at the date of this presentation. This information is given in summary form and does not purport to be complete. Information in this